Ajanta Soya Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:24 pm

Quick Insight

Ajanta Soya Ltd, a company in the Edible Oils & Solvent Extraction industry, currently trades at ₹34.0 with a market capitalization of ₹274 Cr. With a P/E ratio of 10.1 and ROE and ROCE standing at 18.8% and 27.5% respectively, the company demonstrates strong profitability. Notably, Ajanta Soya Ltd's OPM is at 1.57%, indicating potential room for improvement in operational efficiency. The company has a healthy balance sheet with reserves of ₹143 Cr and zero borrowings, reflecting a sound financial position. With a diverse shareholder base and a moderate P/BV of 2.18x, Ajanta Soya Ltd presents an attractive investment opportunity for those seeking exposure to the edible oils sector.

Competitors of Ajanta Soya Ltd

All Competitor Stocks of Ajanta Soya Ltd

Quarterly Result

Last Updated: May 31, 2025, 7:06 am

Below is a detailed analysis of the quarterly data for Ajanta Soya Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 388.39 Cr.. The value appears strong and on an upward trend. It has increased from 365.52 Cr. (Dec 2024) to 388.39 Cr., marking an increase of 22.87 Cr..
• For Expenses, as of Mar 2025, the value is 382.31 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 353.64 Cr. (Dec 2024) to 382.31 Cr., marking an increase of 28.67 Cr..
• For Operating Profit, as of Mar 2025, the value is 6.08 Cr.. The value appears to be declining and may need further review. It has decreased from 11.88 Cr. (Dec 2024) to 6.08 Cr., marking a decrease of 5.80 Cr..
• For OPM %, as of Mar 2025, the value is 1.57%. The value appears to be declining and may need further review. It has decreased from 3.25% (Dec 2024) to 1.57%, marking a decrease of 1.68%.
• For Other Income, as of Mar 2025, the value is 1.70 Cr.. The value appears to be declining and may need further review. It has decreased from 3.58 Cr. (Dec 2024) to 1.70 Cr., marking a decrease of 1.88 Cr..
• For Interest, as of Mar 2025, the value is 0.43 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.31 Cr. (Dec 2024) to 0.43 Cr., marking a decrease of 0.88 Cr..
• For Depreciation, as of Mar 2025, the value is 0.76 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.70 Cr. (Dec 2024) to 0.76 Cr., marking an increase of 0.06 Cr..
• For Profit before tax, as of Mar 2025, the value is 6.59 Cr.. The value appears to be declining and may need further review. It has decreased from 13.45 Cr. (Dec 2024) to 6.59 Cr., marking a decrease of 6.86 Cr..
• For Tax %, as of Mar 2025, the value is 23.98%. The value appears to be improving (decreasing) as expected. It has decreased from 26.91% (Dec 2024) to 23.98%, marking a decrease of 2.93%.
• For Net Profit, as of Mar 2025, the value is 5.02 Cr.. The value appears to be declining and may need further review. It has decreased from 9.83 Cr. (Dec 2024) to 5.02 Cr., marking a decrease of 4.81 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.62. The value appears to be declining and may need further review. It has decreased from 1.22 (Dec 2024) to 0.62, marking a decrease of 0.60.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:08 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:57 pm

Below is a detailed analysis of the balance sheet data for Ajanta Soya Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 16.00 Cr..
• For Reserves, as of Mar 2025, the value is 143.00 Cr.. The value appears strong and on an upward trend. It has increased from 115.00 Cr. (Mar 2024) to 143.00 Cr., marking an increase of 28.00 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 100.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 85.00 Cr. (Mar 2024) to 100.00 Cr., marking an increase of 15.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 259.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 216.00 Cr. (Mar 2024) to 259.00 Cr., marking an increase of 43.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Mar 2024) to 46.00 Cr., marking an increase of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 37.00 Cr.. The value appears strong and on an upward trend. It has increased from 24.00 Cr. (Mar 2024) to 37.00 Cr., marking an increase of 13.00 Cr..
• For Other Assets, as of Mar 2025, the value is 176.00 Cr.. The value appears strong and on an upward trend. It has increased from 148.00 Cr. (Mar 2024) to 176.00 Cr., marking an increase of 28.00 Cr..
• For Total Assets, as of Mar 2025, the value is 259.00 Cr.. The value appears strong and on an upward trend. It has increased from 216.00 Cr. (Mar 2024) to 259.00 Cr., marking an increase of 43.00 Cr..

Notably, the Reserves (143.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Ajanta Soya Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 3.37. This value is below the healthy minimum of 5. It has increased from 0.50 (Mar 24) to 3.37, marking an increase of 2.87.
• For Diluted EPS (Rs.), as of Mar 25, the value is 3.37. This value is below the healthy minimum of 5. It has increased from 0.50 (Mar 24) to 3.37, marking an increase of 2.87.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.73. This value is within the healthy range. It has increased from 0.83 (Mar 24) to 3.73, marking an increase of 2.90.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 19.74. It has increased from 16.24 (Mar 24) to 19.74, marking an increase of 3.50.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 19.74. It has increased from 16.24 (Mar 24) to 19.74, marking an increase of 3.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 165.23. It has increased from 127.00 (Mar 24) to 165.23, marking an increase of 38.23.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 5.32. This value is within the healthy range. It has increased from 1.50 (Mar 24) to 5.32, marking an increase of 3.82.
• For PBIT / Share (Rs.), as of Mar 25, the value is 4.97. This value is within the healthy range. It has increased from 1.16 (Mar 24) to 4.97, marking an increase of 3.81.
• For PBT / Share (Rs.), as of Mar 25, the value is 4.51. This value is within the healthy range. It has increased from 0.63 (Mar 24) to 4.51, marking an increase of 3.88.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 3.37. This value is within the healthy range. It has increased from 0.50 (Mar 24) to 3.37, marking an increase of 2.87.
• For PBDIT Margin (%), as of Mar 25, the value is 3.21. This value is below the healthy minimum of 10. It has increased from 1.18 (Mar 24) to 3.21, marking an increase of 2.03.
• For PBIT Margin (%), as of Mar 25, the value is 3.00. This value is below the healthy minimum of 10. It has increased from 0.91 (Mar 24) to 3.00, marking an increase of 2.09.
• For PBT Margin (%), as of Mar 25, the value is 2.73. This value is below the healthy minimum of 10. It has increased from 0.50 (Mar 24) to 2.73, marking an increase of 2.23.
• For Net Profit Margin (%), as of Mar 25, the value is 2.04. This value is below the healthy minimum of 5. It has increased from 0.39 (Mar 24) to 2.04, marking an increase of 1.65.
• For Return on Networth / Equity (%), as of Mar 25, the value is 17.08. This value is within the healthy range. It has increased from 3.08 (Mar 24) to 17.08, marking an increase of 14.00.
• For Return on Capital Employeed (%), as of Mar 25, the value is 23.93. This value is within the healthy range. It has increased from 6.78 (Mar 24) to 23.93, marking an increase of 17.15.
• For Return On Assets (%), as of Mar 25, the value is 10.48. This value is within the healthy range. It has increased from 1.86 (Mar 24) to 10.48, marking an increase of 8.62.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 5.60. It has increased from 4.56 (Mar 24) to 5.60, marking an increase of 1.04.
• For Current Ratio (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has increased from 2.03 (Mar 24) to 2.18, marking an increase of 0.15.
• For Quick Ratio (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has increased from 0.80 (Mar 24) to 1.06, marking an increase of 0.26.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 10.82. This value exceeds the healthy maximum of 8. It has increased from 8.55 (Mar 24) to 10.82, marking an increase of 2.27.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 11.71. This value is within the healthy range. It has increased from 2.84 (Mar 24) to 11.71, marking an increase of 8.87.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.43. This value is within the healthy range. It has increased from 1.95 (Mar 24) to 8.43, marking an increase of 6.48.
• For Enterprise Value (Cr.), as of Mar 25, the value is 314.58. It has increased from 193.01 (Mar 24) to 314.58, marking an increase of 121.57.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has increased from 0.18 (Mar 24) to 0.23, marking an increase of 0.05.
• For EV / EBITDA (X), as of Mar 25, the value is 7.35. This value is within the healthy range. It has decreased from 15.97 (Mar 24) to 7.35, marking a decrease of 8.62.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 24) to 0.26, marking an increase of 0.05.
• For Price / BV (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has increased from 1.71 (Mar 24) to 2.18, marking an increase of 0.47.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 24) to 0.26, marking an increase of 0.05.
• For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.07, marking an increase of 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness